1. Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial. (25th November 2020) Authors: Pokorney, S; Garonzik, S; Chertow, G.M; Washam, J.B; Mussina, K; Bansal, N; Gadegbeku, C; Garcia, D; Lopes, R.D; Mahaffey, K.W; Middleton, J; Thadhani, R; Thomas, K.L; Winkelmayer, W; Granger, C.B Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗